Formycon AG

Symbol: FYB.DE




Market price today

  • 9.1309

    P/E Ratio

  • -0.0645

    PEG Ratio

  • 761.90M

    MRK Cap

  • 0.00%

    DIV Yield

Formycon AG (FYB-DE) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Biotechnology
CEO:Dr. Stefan Glombitza
Full-time employees:238
Address:Fraunhoferstrasse 15

Formycon AG develops and markets biosimilar products. Its product pipeline includes FYB201, a biosimilar candidate for Lucentis, an ophthalmic drug used in the treatment of neovascular age-related macular degeneration and other serious eye diseases; FYB202, a biosimilar candidate for Stelara, a biopharmaceutical used in the treatment of inflammatory diseases, such as moderate to severe psoriasis, as well as for the treatment of Crohn's disease and ulcerative colitis, which is in the Phase III clinical trial; and FYB203, a biosimilar candidate for Eylea to treat neovascular age-related macular degeneration and other eye diseases that is in Phase III clinical trials. The company is also developing FYB206; and FYB207, an antiviral drug for the treatment of COVID-19. It has a collaboration agreement with Leukocare AG to develop stable formulations for various candidates in its product pipeline. The company was formerly known as Nanohale AG and changed its name to Formycon AG in 2012. Formycon AG was founded in 1999 and is headquartered in Planegg, Germany.

General Outlook

When we look at how much money they make before expenses, they keep 0.300% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.006%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.976%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.085% return, is a testament to Formycon AG's adeptness in optimizing resource deployment. Formycon AG's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.163%. Furthermore, the proficiency of Formycon AG in capital utilization is underscored by a remarkable -0.001% return on capital employed.

Liquidity Ratios

Analyzing FYB.DE liquidity ratios reveals its financial health of the firm. The current ratio of 96.88% gauges short-term asset coverage for liabilities. The quick ratio (79.86%) assesses immediate liquidity, while the cash ratio (39.01%) indicates cash reserves.

Current Ratio96.88%
Quick Ratio79.86%
Cash Ratio39.01%

Profitability Ratios

FYB.DE profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 101.77% underscores its earnings before tax deductions. The effective tax rate stands at 4.14%, revealing its tax efficiency. The net income per EBT, 95.86%, and the EBT per EBIT, -18474.30%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -0.55%, we grasp its operational profitability.

Pretax Profit Margin101.77%
Effective Tax Rate4.14%
Net Income per EBT95.86%
EBT per EBIT-18474.30%
EBIT per Revenue-0.55%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.97, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

Days of Sales Outstanding80
Days of Inventory Outstanding3
Operating Cycle136.10
Days of Payables Outstanding110
Cash Conversion Cycle27
Receivables Turnover2.75
Payables Turnover3.33
Inventory Turnover116.47
Fixed Asset Turnover6.30
Asset Turnover0.09

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.59, and free cash flow per share, -1.91, depict cash generation on a per-share basis. The cash per share value, 1.69, showcases liquidity position. Lastly, the operating cash flow sales ratio, -0.12, offers insight into cash flow relative to sales.

Operating Cash Flow per Share-0.59
Free Cash Flow per Share-1.91
Cash per Share1.69
Operating Cash Flow Sales Ratio-0.12
Free Cash Flow to Operating Cash Flow Ratio3.25
Cash Flow Coverage Ratio-0.32
Short Term Coverage Ratio-0.43
Capital Expenditure Coverage Ratio-0.44
Dividend Paid and Capex Coverage Ratio-0.44

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 3.31%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.06, we discern the balance between debt and equity financing. The long-term debt to capitalization, 1.53%, and total debt to capitalization, 5.54%, ratios shed light on its capital structure. An interest coverage of -4.46 indicates its ability to manage interest expenses.

Debt Ratio3.31%
Debt Equity Ratio0.06
Long Term Debt to Capitalization1.53%
Total Debt to Capitalization5.54%
Interest Coverage-4.46
Cash Flow to Debt Ratio-0.32
Company Equity Multiplier1.77

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 4.88, provides a glimpse into top-line earnings distributed across each share. Net income per share, 4.76, reflects the portion of profit attributed to each share. The book value per share, 31.59, represents the net asset value distributed per share, while the tangible book value per share, -3.15, excludes intangible assets.

Revenue Per Share4.88
Net Income Per Share4.76
Book Value Per Share31.59
Tangible Book Value Per Share-3.15
Shareholders Equity Per Share31.59
Interest Debt Per Share1.86
Capex Per Share-1.33

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 82.83%, indicates top-line expansion, while the gross profit growth, 93.05%, reveals profitability trends. EBIT growth, 97.59%, and operating income growth, 97.59%, offer insights into operational profitability progression. The net income growth, 110.59%, showcases bottom-line expansion, and the EPS growth, 81.68%, measures the growth in earnings per share.

Revenue Growth82.83%
Gross Profit Growth93.05%
EBIT Growth97.59%
Operating Income Growth97.59%
Net Income Growth110.59%
EPS Growth81.68%
EPS Diluted Growth82.24%
Weighted Average Shares Growth16.04%
Weighted Average Shares Diluted Growth15.59%
Operating Cash Flow Growth50.51%
Free Cash Flow Growth33.13%
10-Year Revenue Growth per Share17576.21%
5-Year Revenue Growth per Share6.99%
3-Year Revenue Growth per Share56.89%
10-Year Operating CF Growth per Share64.53%
5-Year Operating CF Growth per Share-141.85%
3-Year Operating CF Growth per Share-24.76%
10-Year Net Income Growth per Share715.23%
5-Year Net Income Growth per Share532.13%
3-Year Net Income Growth per Share984.03%
10-Year Shareholders Equity Growth per Share2478.47%
5-Year Shareholders Equity Growth per Share795.44%
3-Year Shareholders Equity Growth per Share410.72%
Receivables Growth82.90%
Inventory Growth-18.21%
Asset Growth4.29%
Book Value per Share Growth21.50%
Debt Growth-40.20%
R&D Expense Growth-45.83%
SGA Expenses Growth13.06%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 888,960,447.3, captures the company's total value, considering both debt and equity. Income quality, -0.12, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.17, gauges operational efficiency, while the research and development to revenue, 11.79%, highlights investment in innovation. The ratio of intangibles to total assets, 62.10%, indicates the value of non-physical assets, and capex to operating cash flow, 225.47%, measures reinvestment capability.

Enterprise Value888,960,447.3
Income Quality-0.12
Sales General and Administrative to Revenue0.17
Research and Development to Revenue11.79%
Intangibles to Total Assets62.10%
Capex to Operating Cash Flow225.47%
Capex to Revenue-27.28%
Capex to Depreciation-1123.26%
Stock-Based Compensation to Revenue2.09%
Graham Number58.18
Return on Tangible Assets22.46%
Graham Net Net-21.31
Working Capital-2,159,000
Tangible Asset Value-50,185,000
Net Current Asset Value-320,464,000
Average Receivables21,889,500
Average Payables13,818,499.5
Average Inventory519,000
Days Sales Outstanding133
Days Payables Outstanding110
Days of Inventory On Hand3

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.38, and the price to book ratio, 1.38, reflect the market's valuation relative to the company's book value. The price to sales ratio, 9.81, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -24.90, and price to operating cash flows, -73.62, gauge market valuation against cash flow metrics.

Price Book Value Ratio1.38
Price to Book Ratio1.38
Price to Sales Ratio9.81
Price Cash Flow Ratio-73.62
Price Earnings to Growth Ratio-0.06
Enterprise Value Multiple520.52
Price Fair Value1.38
Price to Operating Cash Flow Ratio-73.62
Price to Free Cash Flows Ratio-24.90
Price to Tangible Book Ratio1.76
Enterprise Value to Sales11.44
Enterprise Value Over EBITDA609.29
EV to Operating Cash Flow-94.56
Earnings Yield8.55%
Free Cash Flow Yield-3.45%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Formycon AG (FYB.DE) on the XETRA in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 9.131 in 2024.

What is the ticker symbol of Formycon AG stock?

The ticker symbol of Formycon AG stock is FYB.DE.

What is company IPO date?

IPO date of Formycon AG is 2011-01-04.

What is company current share price?

Current share price is 43.150 EUR.

What is stock market cap today?

The market cap of stock today is 761895235.000.

What is PEG ratio in 2024?

The current -0.065 is -0.065 in 2024.

What is the number of employees in 2024?

In 2024 the company has 238.